What are the results of the following studies on reducing bleeding during myomectomy?
Comparison of the efficacy of tourniquet with uterine artery ligation
Use of oxytocin during myomectomy
Use of misoprostol before laparotomy myomectomy
In the first study, the group that underwent uterine artery ligation had significantly lower blood transfusion rates and peroperative bleeding compared to the tourniquet group, without an increase in peroperative complications.
In the second study, the use of a tourniquet during the intervention resulted in significantly lower surgical bleeding and blood transfusion rates in the group that underwent uterine artery ligation compared to the tourniquet group.
A meta-analysis of two randomized studies found no benefit in using oxytocin during myomectomy, either on peroperative bleeding or the risk of transfusion.
In the first study on the use of misoprostol, the group that received the medication had significantly lower blood loss, surgical duration, blood transfusion rates, and surgical duration compared to the group that did not receive misoprostol.
In the second study on the use of misoprostol, the group that received the medication had significantly lower blood transfusion rates and blood loss compared to the control group.
a) Only the first and second studies showed benefits in reducing bleeding during myomectomy.
b) Only the second and third studies showed benefits in reducing bleeding during myomectomy.
c) Only the first and third studies showed benefits in reducing bleeding during myomectomy.
d) Only the first, fourth, and fifth studies showed benefits in reducing bleeding during myomectomy.
e) All studies showed benefits in reducing bleeding during myomectomy.